
The products available on this website are intended exclusively for research and professional use. They are not approved by the FDA for human consumption, diagnosis, treatment, or prevention of any disease.
By entering this site, you confirm that you are a qualified researcher, licensed professional, or otherwise authorized to purchase research-grade compounds, and that you will use these products solely for lawful research purposes.
This notice is displayed in compliance with applicable regulations governing the sale of research compounds. Human Upgrade Labs does not condone or encourage the misuse of any research products.
Your cart is empty

LL-37 is the only known human cathelicidin antimicrobial peptide, derived from the C-terminal region of the human cationic antimicrobial protein 18 (hCAP18). Research has demonstrated broad-spectrum antimicrobial activity, immune modulation, wound healing promotion, and anti-biofilm properties.
Lyophilized: -20°C. Reconstituted: 2–8°C.

C-terminal α-MSH tripeptide with potent anti-inflammatory and gut healing research.

Antiparasitic compound with emerging research in immune modulation.

Thymic peptide for immune modulation, antiviral, and anti-tumor research.
FOR RESEARCH PURPOSES ONLY · NOT FOR HUMAN OR ANIMAL CONSUMPTION · NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE